Rigel Pharmaceuticals Inc (RIGL)
14.20
+0.57
(+4.18%)
USD |
NASDAQ |
Nov 01, 16:00
14.12
-0.08
(-0.56%)
After-Hours: 20:00
Rigel Pharmaceuticals Revenue (Quarterly): 36.84M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 36.84M |
| March 31, 2024 | 29.53M |
| December 31, 2023 | 35.79M |
| September 30, 2023 | 28.13M |
| June 30, 2023 | 26.89M |
| March 31, 2023 | 26.07M |
| December 31, 2022 | 51.28M |
| September 30, 2022 | 22.41M |
| June 30, 2022 | 29.82M |
| March 31, 2022 | 16.74M |
| December 31, 2021 | 20.41M |
| September 30, 2021 | 21.54M |
| June 30, 2021 | 26.27M |
| March 31, 2021 | 81.02M |
| December 31, 2020 | 18.45M |
| September 30, 2020 | 18.39M |
| June 30, 2020 | 16.02M |
| March 31, 2020 | 55.76M |
| December 31, 2019 | 15.40M |
| September 30, 2019 | 20.86M |
| June 30, 2019 | 10.41M |
| March 31, 2019 | 12.62M |
| December 31, 2018 | 37.86M |
| September 30, 2018 | 4.865M |
| June 30, 2018 | 1.787M |
| Date | Value |
|---|---|
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | 0.90M |
| June 30, 2017 | |
| March 31, 2017 | 3.584M |
| December 31, 2016 | 3.00M |
| September 30, 2016 | 3.76M |
| June 30, 2016 | 8.594M |
| March 31, 2016 | 5.029M |
| December 31, 2015 | 8.537M |
| September 30, 2015 | 13.00M |
| June 30, 2015 | 5.184M |
| March 31, 2015 | 2.178M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 5.75M |
| September 30, 2013 | |
| June 30, 2013 | 1.40M |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | 1.50M |
| March 31, 2012 | 0.75M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
15.40M
Minimum
Dec 2019
81.02M
Maximum
Mar 2021
30.36M
Average
26.27M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | 225.25M |
| Collegium Pharmaceutical Inc | 145.28M |
| NovaBay Pharmaceuticals Inc | 2.40M |
| Palatin Technologies Inc | 0.35M |
| iBio Inc | 0.175M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.03M |
| Total Expenses (Quarterly) | 36.39M |
| EPS Diluted (Quarterly) | -0.06 |
| Enterprise Value | 260.44M |
| Gross Profit Margin (Quarterly) | 92.38% |
| Profit Margin (Quarterly) | -2.80% |
| Earnings Yield | -5.35% |
| Normalized Earnings Yield | -5.352 |